Romance is the name of the game on Valentine’s Day, and keeping sneezing, wheezing and watery eyes out of the mix helps put everyone more in the mood for love. Here are five tips from ACAAI to help make your Valentine’s Day special.
Dr. Thomas Egan of the University of North Carolina School of Medicine says that a recent change in donor lung allocation policy was long overdue. However, because the change happened over the Thanksgiving holiday weekend in response to litigation, it came as a “tsunami” that was “sudden, unexpected, and may have huge consequences.”
Temple University Hospital (TUH) performed 131 lung transplants in calendar year 2017, making it the number 1 volume program in the nation according to data just released by the United Network for Organ Sharing (UNOS).
By analyzing immune cells of children who came to the emergency department with flu symptoms, researchers found that the suite of genes these early-response cells expressed was shaped by factors such as age and previous exposures to viruses. Better understanding how early infections influence long-term immune response has implications for the diagnosis and treatment of young patients who suffer from acute respiratory tract infections.
Asthma costs the U.S. economy more than $80 billion annually in medical expenses, missed work and school days and deaths, according to new research published online in the Annals of the American Thoracic Society.
Researchers at UT Southwestern’s Simmons Cancer Center have shown that RAS molecules act in pairs, known as dimers, to cause cancer, findings that could help guide them to a treatment.
Beginning on May 20*, the ATS 2018 International Conference in San Diego will give journalists like you what they have come to expect from the biggest gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine. Register now
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these treatments and in turn have lower overall survival, according to research from The University of Texas MD Anderson Cancer Center.
Jonathan A. Epstein, MD, executive vice dean and chief scientific officer of Penn Medicine, has received a National Heart, Lung, and Blood Institute (NHLBI) Outstanding Investigator Award. The highly competitive award provides long-term support to “an experienced investigator with an outstanding record of research productivity.” In issuing the award, the NHLBI, which is part of the National Institutes of Health, described Epstein as “an outstanding, pioneering investigator” and “a gold standard role model for physician-scientists in the field.”
The American Thoracic Society Foundation has announced that 16 researchers have been awarded unrestricted research grants totaling more than $1 million to advance pulmonary, critical care and sleep medicine around the world. These one-year, $40,000 grants can be used to support basic science, patient-oriented, and public health research.
University of Colorado Cancer Center study shows that radiosurgery may effectively treat brain metastases associated with certain types of lung cancer, even when the number of metastases exceeds established norms.
An online survey of 900 consumers of three of the United States’ most popular cigarette brands suggests that adopting standardized cigarette packing may reduce consumers’ misconceptions that some cigarettes are less harmful than others, reports a team of researchers led by University of California San Diego School of Medicine and published in BMJ Tobacco Control.
SEATTLE – (Dec. 18, 2017) –Virginia Mason has become the first health system in Washington state to begin a new therapy that targets neuroendocrine tumors, an uncommon cancer that affects the intestines, pancreas, lungs and other parts of the body.
Tomorrow, ministers at the 15th ministerial council meeting of the Energy Community in Kosovo will adopt new rules for emission limits for coal power plants in the Western Balkans (as part of the transposition of the EU’s Industrial Emissions Directive into national law).
Researchers at The Johns Hopkins University report statistical evidence that children exposed to airborne coarse particulate matter — a mix of dust, sand and non-exhaust tailpipe emissions, such as tire rubber — are more likely to develop asthma and need emergency room or hospital treatment for it than unexposed children.
Children exposed to coarse particulate matter may be more likely to develop asthma and to be treated in an ER or be hospitalized for the condition, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis.
This past weekend brought fierce Santa Ana Winds to Southern California that are expected to last all week. As of this writing, major fires are burning in Ventura County and other areas within Los Angeles County. The South Coast Air Quality Management District lists the following areas of direct smoke impacts: ftp://ftp.aqmd.gov/pub/globalist/Advisory2.pdf
Remember when your mom always told you “what you do now will catch up with you when you’re older?” She wasn’t lying. Lung cancer is a disease that mostly affects the elderly, with 83 percent of those living with cancer being 60-years-of-age or older, but reducing your risk of getting lung cancer starts when you’re young.
Dec. 5, 2017─Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.
Ann & Robert H. Lurie Children’s Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years. Based on these results, Vertex Pharmaceuticals Inc., (Nasdaq: VRTX) plans to submit applications for the drug in this age group to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Kalydeco is currently approved by the FDA for the treatment of cystic fibrosis in patients aged 2 years and older.
DNA sequences between mitochondria within a single cell are vastly different, found researchers. This knowledge will help to better illuminate the underlying mechanisms of many disorders that start with accumulated mutations in individual mitochondria and provide clues about how patients might respond to specific therapies.
A team of physicians, scientists and biostatisticians from La Jolla Institute for Allergy and Immunology and UC San Diego School of Medicine joined forces across institutions to successfully compete for an $6.9 million grant to establish one of only 10 PrecISE Network Clinical Centers nationwide.
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
TIna Farber arrived in Arkansas with one thing on her mind — meeting her two new grandbabies. Her son’s third child had arrived in April, and her daughter was expecting her third about one month later.
Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition — which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment — are more likely to invade and spread to other parts of the body, according to a new study led by researchers from Mass. Eye and Ear, Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard.
Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice.
Patients with early stage lung cancer live longer when they receive a lobectomy—the most common type of operation for the disease—rather than a less extensive operation or radiation treatment.
A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health.
The study from the University of Notre Dame and Michigan State University could help researchers identify how to tone down the ability of mycobacteria to cause disease and help them in treating infection.
While new CF drugs are life-changing for some patients, they don’t work for everyone. Now, UNC and UAB researchers present a simple test that aims to predict which treatment is most likely to work for each patient, an approach known as personalized or precision medicine.
A large multicenter study found that patients with cystic fibrosis (CF) – who tend to develop chronic lung infections – had more good and bad bacteria in their lungs compared to controls. The study used bronchoalveolar lavage, in which a bronchoscope is directed into the lung to directly collect lung secretions, and also found less diversity of bacteria in the lungs of CF patients who were older and had more lung disease or inflammation. Results, published in the European Respiratory Journal, provide a basis for future treatment studies.
Sinus infections, inflammation and nasal congestion constantly plague Americans, often leading to unpleasant symptoms and even missed days of work. Traditional nasal spray anti-inflammatory medications attempt to treat the symptoms noninvasively, but are not very efficient in transmitting the active drug ingredients directly into the sinus cavities. Researchers from the University of North Carolina will present their research on the anatomy-based flow physics in nasal cavities which generate “magical” streamlines for sinus drug delivery at the 70th meeting of the Division of Fluid Dynamics, Nov. 19-21, 2017.
UNC School of Medicine researchers have developed a new laboratory model to measure and compare the responses of CF and normal airway cells to CF-related infectious/inflammatory factors.
The American Thoracic Society (ATS) and the Japanese Respiratory Society (JRS) have published additional clinical practice guidelines regarding four specific questions related to the diagnosis of lymphangioleiomyomatosis (LAM) and management of pneumothoraces in patients with LAM.
The court-ordered publication of “corrective statements” by major U.S. tobacco companies later this month should serve as a reminder that tobacco addiction remains a major health problem in the country and that Big Tobacco has a long history of marketing practices aimed at hooking a new generation on a lethal product, according to an editorial published online in the Annals of the American Thoracic Society.
New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians.
A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver” mutation that can be treated in isolation with a single targeted drug.
Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?
An article in the Annals of Allergy, Asthma and Immunology guides medical professionals through the principles involved in using new treatments for severe asthma.
New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.
Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.
The ATS Foundation continues to support researchers committed to improving the lives of patients with respiratory disease. Today, the Foundation announces its new ATS Foundation/Boehringer Ingelheim Research Fellowship in idiopathic pulmonary fibrosis. The fellowship will award $100,000 over two years.